| http://www.w3.org/ns/prov#value | - binationsUS6710087Jun 4, 2002Mar 23, 2004Sepracor, Inc.For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, painUS6730325May 7, 2001May 4, 2004Elan Corporation, PlcMultiparticulate modified release compositionUS6743445May 3, 2002Ju
|
